Editas Medicine, Inc.
EDIT
$2.90
-$0.03-1.02%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -39.22% | -19.16% | 12,265.57% | 597.47% | 310.40% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -39.22% | -19.16% | 12,265.57% | 597.47% | 310.40% |
| Cost of Revenue | -33.82% | -43.63% | -58.49% | -70.15% | -45.49% |
| Gross Profit | 32.67% | 85.21% | 74.29% | 76.53% | 53.97% |
| SG&A Expenses | -23.48% | -30.58% | -31.91% | -29.37% | -30.84% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -30.36% | -40.34% | -51.18% | -59.90% | -41.33% |
| Operating Income | 29.19% | 59.21% | 62.62% | 64.59% | 47.29% |
| Income Before Tax | 67.17% | 87.62% | 59.58% | 21.26% | -22.82% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 67.17% | 87.62% | 59.58% | 21.26% | -22.82% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 67.17% | 87.62% | 59.58% | 21.26% | -22.82% |
| EBIT | 29.19% | 59.21% | 62.62% | 64.59% | 47.29% |
| EBITDA | 26.57% | 57.64% | 62.81% | 66.48% | 49.08% |
| EPS Basic | 72.14% | 89.48% | 62.99% | 23.22% | -21.16% |
| Normalized Basic EPS | 40.82% | 75.17% | 63.00% | 60.85% | 42.96% |
| EPS Diluted | 72.14% | 89.48% | 62.99% | 23.22% | -21.16% |
| Normalized Diluted EPS | 40.82% | 75.17% | 63.00% | 60.85% | 42.96% |
| Average Basic Shares Outstanding | 17.85% | 17.72% | 9.22% | 2.55% | 1.36% |
| Average Diluted Shares Outstanding | 17.85% | 17.72% | 9.22% | 2.55% | 1.36% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |